Skip to main content
. 2018 Aug 21;23(9):2097. doi: 10.3390/molecules23092097

Figure 7.

Figure 7

The MOR/α-CD inhibition activity against the ATCC BAA-977 CC-resistant strain. The experiment was carried out adding 1 mg/mL of MOR/α-CD for each microplate well filled with the combined doses of CC (1, 0.5, 0.25, 0.125, 0.06 mg/mL) and Ery (from 2 mg/mL to 0.002 mg/mL). The MOR/α-CD inhibition activity was evaluated by measuring the OD reached after 24 h of treatment. The experiments were assessed in triplicate to obtain the mean and the standard deviation (SD). A statistical analysis (Two way ANOVA) was performed by the GraphPad Prism6 software and the p value < 0.0001 (****) showed a significant difference between the treatment with 1 mg/mL of MOR/α-CD of the resistant strain in each combined well and the untreated bacteria (0 mg/mL).